-
Billionbrains
208.75 112.02(%) -
Lenskart Solut.
733.10 767.40(%) -
NSE
1,953.95 1,953.95(%) -
Cartrade Tech
2,712.90 3,291.35(%) -
Apar Inds.
13,783.50 6,800.00(%) -
Tonbo Imaging
1,427.75 1,013.95(%) -
M & M
3,295.00 3,840.00(%) -
Cummins India
3,903.00 3,883.30(%) -
HDFC Bank
787.00 1,017.90(%) -
ICICI Bank
1,569.30 1,569.30(%) -
Sai Life
1,815.55 1,815.55(%) -
Hitachi Energy
26,720.00 16,104.00(%) -
Avenue Super.
3,408.40 3,104.00(%) -
Axis Bank
1,323.90 1,418.30(%) -
Bharti Airtel
2,120.00 2,174.70(%) -
Larsen & Toubro
4,118.90 4,440.00(%) -
Jio Platforms
1,390.00 1,356.40(%) -
CG Power & Ind
734.00 525.50(%) -
Reliance Industries
1,318.10 1,611.20(%) -
SBI
1,020.00 1,234.80(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Skybiotech Healthcare Limited Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 2250.0
- ISIN : INE393H01016
-
Today’s Low
114.50 -
Today’s High
115.00
-
Open
115.00 -
Perv Close
115.00 -
52W Low
113.70 -
52W High
218.20
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
21.93
-
Div & Yield %
0.00
-
Book Value(₹)
60.33
-
Debt-Equity Ratio
-0.43
-
AGM Date
05-Nov-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
21.93
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
1.92
-
BV (₹)
60.30
-
Sales( ₹ in Cr.)
0.00
-
NP (in Cr.)
-0.06
-
NP Var(%)
27.0
-
Div%
0.0
-
CPS (₹)
-0.30
-
EPS (₹)
-0.30
-
Traded Value (₹ in Lakhs)
21.93
-
52 Week High
218.20
-
52 Week Low
113.70
-
Price BSE
115.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
21.93
-
P/C Ratio
-347.20
-
P/E Ratio
-346.70
-
Price Vs.BV
-0.30
-
05-Nov-2026( 02:43)
Corporate News - Skybi... - <p>Skybiotech Healthcare Limit...
-
01-Oct-2026( 02:12)
Corporate News - Skybi... - <p>Skybiotech Healthcare Limit...
-
11-Aug-2026( 04:08)
Corporate News - Skybi... - Skybiotech Healthcare Limited,...
-
01-Jun-2026( 07:34)
Results - Announcements - Skybi... - Net Loss of Skybiotech Healthc...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.07 | 0.18 | 2.00 | 0.05 | 0.02 | 0.02 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.07 | 0.18 | 2.00 | 0.05 | 0.02 | 0.02 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Cost | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 0.11 | 0.09 | 0.11 | 0.05 | 0.04 | 0.05 |
| Miscellaneous Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expenses | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 0.13 | 0.10 | 0.13 | 0.06 | 0.06 | 0.07 |
| Operating Profit | -0.06 | 0.08 | 1.88 | -0.01 | -0.04 | -0.05 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -0.06 | 0.08 | 1.88 | -0.01 | -0.04 | -0.05 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | -0.06 | 0.08 | 1.88 | -0.01 | -0.04 | -0.05 |
| Current Tax | 0.00 | 0.02 | 0.34 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -0.06 | 0.06 | 1.54 | -0.01 | -0.04 | -0.05 |
| Extraordinary Items | 0.00 | 0.15 | 1.53 | 0.02 | -0.01 | 0.00 |
| Adjusted Net Profit | -0.06 | -0.09 | 0.01 | -0.03 | -0.03 | -0.05 |
| Adjustment below Net Profit | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 1.80 | 1.59 | 0.05 | 0.06 | 0.09 | 0.14 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 1.74 | 1.80 | 1.59 | 0.05 | 0.06 | 0.09 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -0.32 | 0.31 | 8.02 | -0.07 | -0.36 | -0.46 |
| Earnings Per Share(Adj)-Unit Curr | -0.32 | 0.31 | 8.02 | -0.07 | -0.36 | -0.46 |
| Book Value | 60.33 | 61.51 | 56.56 | 33.55 | 35.76 | 30.92 |
| Book Value(Adj)-Unit Curr | 60.33 | 61.51 | 56.56 | 33.55 | 35.76 | 30.92 |
